Angiotensin converting enzyme inhibitors (ACE-I) and HMGCoA reductase inhibitors (`statins') have been shown to reduce
Angiotensin converting enzyme inhibitors (ACE-I) and HMGCoA reductase inhibitors (`statins') have been shown to reduce CVD risk through their BP and cholesterol lowering properties, respectively . However, both classes of…